Biomonitoring

Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical

Retrieved on: 
Thursday, July 21, 2022
Diabetes, Health Technology, Health, Medical Supplies, Acquisition, Tandem, Diabetes, Industry, Twitter, U.S. Securities and Exchange Commission, Biomonitoring, Solution, Securities Act of 1933, Securities Exchange Act of 1934, NASDAQ, Tandem Diabetes Care, Review, Technology, FDA, Company, Security (finance), Insulin, Annual report, Drug Quality and Security Act, Medical device

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary Biomedical.

Key Points: 
  • Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced its acquisition of infusion set developer, Capillary Biomedical.
  • Capillary Biomedicals unique extended wear infusion set technology is currently in development and not commercially available.
  • Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience.
  • Tandem Diabetes Care, Control-IQ, and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.

Wildnote CEO Kristen Hazard Receives 2021 EBJ Business Achievement Award

Retrieved on: 
Monday, February 28, 2022
Public policy, GLOBE, Enterprise, Software as a service, Compliance, Natural Resources, Digitization, Environment, CA, EBI, EBJ, Consultant, SLO, Biomonitoring, Hyco International Inc, SAN, Technology, CEO, Research, Green Zone Community Climate Action, Time, Renewable energy, Centre for Industry Education Collaboration

SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Environmental Business Journal (EBJ), a business research publication that provides high-value strategic business intelligence to the environmental industry, has honored Kristen Hazard, Wildnote CEO, with a Business Achievement Award for Industry Leadership in 2021.

Key Points: 
  • SAN DIEGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Environmental Business Journal (EBJ), a business research publication that provides high-value strategic business intelligence to the environmental industry, has honored Kristen Hazard, Wildnote CEO, with a Business Achievement Award for Industry Leadership in 2021.
  • Hazard, founder and CEO of Wildnote (San Luis Obispo, Calif.) and developer of the company's groundbreaking environmental compliance reporting software, was selected for her contributions to Industry Education, Public Policy Dialog, and Community Climate and Energy Action.
  • Throughout 2021, Kristen hosted free monthly webinars engaging industry experts with a wide audience to share best practices for integrating technology into environmental consulting activities.
  • *The Wildnote mission is to help protect natural resources by automating the process of environmental compliance.

Major Advances in Diagnosing Cancers Associated With the Human Papillomavirus

Retrieved on: 
Wednesday, November 24, 2021
Research, Infectious Diseases, Hospitals, Genetics, Other Health, Biotechnology, Health, Science, Oncology, Other Science, Patient, Institute, HPV, Biomonitoring, Cancer, Time, National Healthcare Group, ICL, Neoplasm, Diagnosis, Recurrence, Prevalence, Virus, Blood, Nature, Clinical Cancer Research, NGS, DNA, Research, X-ray, Knowledge, Immunotherapy, Immune system, Multimedia, Vaccine, Medical imaging

Faced with the difficulty of distinguishing between tumour DNA and non-tumour DNA, ICL teams concentrated their efforts on types of cancers caused by viruses, specifically human papillomaviruses (HPV).

Key Points: 
  • Faced with the difficulty of distinguishing between tumour DNA and non-tumour DNA, ICL teams concentrated their efforts on types of cancers caused by viruses, specifically human papillomaviruses (HPV).
  • They decided to test the hypothesis that it was possible to diagnose cancers associated with these viruses, regardless of the type of cancer or type of virus, in a different way.
  • In certain situations, diagnosing HPV-associated cancer can be difficult using traditional approaches that rely on collecting a tumour tissue sample.
  • In the long term, the work being conducted specifically on tumours associated with human papillomavirus should pave the way to optimizing diagnosis and monitoring of tumours associated with other viruses.

Green Products Innovator The ROOT Brand Releases Patented CleanSlate Formula to Help Purge Heavy Metals and Toxins

Retrieved on: 
Thursday, October 21, 2021
GMO, Research, Mineral, Operation Cleanslate, Knowledge, Happiness, Biomonitoring, TOXIC, Urine, Zeolite, Brand, Cell, Solution, Health, ROOT, Education, Pharmaceutical industry

NASHVILLE, Tenn., Oct. 21, 2021 /PRNewswire/ -- The ROOTBrand nature-inspired products firm introduces CleanSlate tohelp wipe cells clean of toxins.

Key Points: 
  • NASHVILLE, Tenn., Oct. 21, 2021 /PRNewswire/ -- The ROOTBrand nature-inspired products firm introduces CleanSlate tohelp wipe cells clean of toxins.
  • CleanSlateis an advancement in the process created by Dr. Christina Rahm Cook, Ph.D.," said Clayton Thomas, The ROOT Brand founder.
  • The ROOT Brand is a health and wellness companywith a mission toget to the "ROOT" of health problems.All The Root Brandproducts are non-GMO, organic, vegan and gluten-free.
  • "We all have a body burden, which means the body's ability to naturally remove heavy metals and toxins.

Government of Canada releases the latest results of the Canadian Health Measures Survey

Retrieved on: 
Tuesday, December 15, 2020
Articles, Government of Canada, Analytical chemistry, Biomonitoring, Environmental chemistry, Medical monitoring, Health Canada, Environmental social science, Occupational safety and health, Public Health Agency of Canada, Health, Bioindicator

OTTAWA, ON, Dec. 15, 2020 /CNW/ -This week, Health Canadaand Statistics Canada released new results from the biomonitoring component of the Canadian Health Measures Survey (CHMS).

Key Points: 
  • OTTAWA, ON, Dec. 15, 2020 /CNW/ -This week, Health Canadaand Statistics Canada released new results from the biomonitoring component of the Canadian Health Measures Survey (CHMS).
  • The biomonitoring component of the CHMScollects meaningful data that informs evidence-based decisions to protect the health and safety of Canadians.
  • The national biomonitoring initiative of the Canadian Health Measures Survey is part of the Government's actions on chemicals, including the Chemicals Management Plan , and is an important component of thevision for a healthy Canada.
  • The CHMS is led by Statistics Canada in partnership with Health Canada and the Public Health Agency of Canada.

PerkinElmer Launches Solutions to Streamline Analysis for Labs in Pharmaceuticals, Semiconductors, Biomonitoring, Food and Materials

Retrieved on: 
Monday, April 20, 2020
Technology, Chemicals, Plastics, Manufacturing, Biotechnology, Health, Pharmaceutical, Other Science, Science, Consumer electronics, Analytical chemistry, Natural sciences, Analysis, Science, Laboratory equipment, Infrared spectroscopy, Fourier-transform infrared spectroscopy, Agilent Technologies, Biomonitoring, Inductively coupled plasma mass spectrometry, Spectroscopy

Geared for pharmaceutical, semiconductor, biomonitoring, food, materials and academia labs, the new offerings will help streamline workflows, sharpen insights and performance and provide ease of use.

Key Points: 
  • Geared for pharmaceutical, semiconductor, biomonitoring, food, materials and academia labs, the new offerings will help streamline workflows, sharpen insights and performance and provide ease of use.
  • They include:
    NexION 5000 Multi-Quadruple ICP-MS for demanding trace element analyses, this solution drives accurate and repeatable results and helps future-proof labs.
  • Spectrum 3 spectrometer a tri-range FT-IR spectroscopy solution featuring 100 scans/second for pharmaceutical, polymer, materials, food, academic or chemical labs doing advanced research, product development or reaction monitoring.
  • With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets.